INMUNE BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.6 USD | -2.03% |
|
+9.23% | +3.02% |
Chart calendar INmune Bio, Inc.
2b84d41d4796fbcc456a3b2f2.eGRxRPP-edNX_cfZIFFRUdJ1nTUl8yyeqQk_Zl9Gakg.HSowAKOxP4sWmLOtWgQVZIME2UYIq2707XpzHAgSUgAsXDYotY8L4BPNtA~d88c41fde9f56791a317bc25e36c5476
Upcoming events on INmune Bio, Inc.
Past events on INmune Bio, Inc.
| 01/05/2024 | Q1 2024 Earnings Release (Projected) |
| 09/04/2024 02:00 am | American Association for Cancer Research Meeting - POster No PO.TB04.02 |
| 08/04/2024 09:30 pm | American Association for Cancer Research Meeting - Poster No PO.IM01.02 |
| 29/03/2024 02:00 am | Q4 2023 Earnings Call |
| 29/03/2024 01:31 am | Q4 2023 Earnings Release |
| 14/02/2024 09:50 pm | Oppenheimer Healthcare Life Sciences Conference |
| 13/02/2024 09:00 pm | Baird Biotech Discovery Series |
| 05/12/2023 | San Antonio Breast Cancer Symposium |
| 02/11/2023 02:00 am | Q3 2023 Earnings Call |
| 02/11/2023 01:40 am | Q3 2023 Earnings Release |
| 24/10/2023 | Clinical Trial in Alzheimer Disease Conference |
| 14/09/2023 01:00 am | H.C. Wainwright Global Investment Conference |
| 13/09/2023 11:30 pm | Baird Global Healthcare Conference |
| 08/08/2023 02:00 am | Q2 2023 Earnings Call |
| 08/08/2023 01:30 am | Q2 2023 Earnings Release |
| 07/08/2023 09:30 pm | BTIG Virtual Biotechnology Conference |
| 17/07/2023 12:30 pm | World Aging and Rejuvenation Conference |
| 08/07/2023 | XVI European Glial Cells in Health and Disease Meeting |
| 20/06/2023 09:30 pm | Maxim Group Virtual Healthcare Conference |
| 01/06/2023 07:30 pm | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,01 0,00 - | 0,18 0,01 1596.34% | 0,37 0,20 91.3% | 0,16 0,14 9.67% | 0,04 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -7,76 -8,80 11.84% | -12,2 -13,2 7.31% | -29,2 -29,8 2.33% | -26,0 -29,3 11.36% | -29,7 -29,1 -2.23% | -41,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,68 -8,24 6.8% | -12,1 -13,0 7.14% | -30,3 -30,3 -0.16% | -27,3 -29,8 8.3% | -30,0 -29,7 -1.17% | -41,2 |
|
Net income Million USD | Released Forecast Spread | -7,68 -8,24 6.8% | -12,1 -13,0 7.14% | -30,3 -30,3 -0.16% | -27,3 -29,8 8.3% | -30,0 -29,7 -1.17% | -41,2 |
|
EPS USD | Released Forecast Spread | -0,75 -0,79 5.46% | -1,01 -1,09 7.34% | -1,88 -1,91 1.74% | -1,52 -1,66 8.43% | -1,67 -1,65 -1.21% | -2,22 |
| Announcement Date | 11/03/20 | 04/03/21 | 03/03/22 | 02/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,16 0,00 - | 0,16 0,00 - | 0,02 0,00 - | 0,10 0,00 - | 0,10 0,00 - | 0,05 0,01 263.06% | 0,04 0,02 180.5% | 0,03 0,01 95.39% | 0,03 | 0,03 | 0,03 | 0,03 | |
|
EBIT Million USD | Released Forecast Spread | -9,03 -9,73 7.21% | -6,48 -10,1 35.86% | -6,39 -8,16 21.75% | -7,44 -9,22 19.29% | -5,64 -8,86 36.3% | -6,41 -7,18 10.7% | -8,53 -7,06 -20.76% | -8,38 -7,73 -8.38% | -9,68 | -10,9 | -12,3 | -13,7 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,67 -9,65 -0.24% | -6,90 -10,8 36.08% | -6,84 -8,23 16.92% | -7,73 -9,33 17.19% | -5,83 -8,77 33.5% | -6,50 -7,17 9.28% | -8,56 -7,04 -21.56% | -8,41 -7,70 -9.18% | -9,64 | -10,9 | -12,2 | -13,7 | |
|
Net income Million USD | Released Forecast Spread | -9,67 -9,65 -0.24% | -6,90 -10,5 34.32% | -6,84 -8,23 16.92% | -7,73 -9,33 17.19% | -5,83 -8,77 33.5% | -6,54 -0,44 -1385.45% | -6,50 -7,17 9.28% | -8,56 -7,04 -21.56% | -8,41 -7,70 -9.18% | -9,64 | -10,9 | -12,2 | -13,7 |
|
EPS USD | Released Forecast Spread | -0,55 -0,58 4.62% | -0,39 -0,64 39.06% | -0,38 -0,49 21.92% | -0,43 -0,55 21.34% | -0,32 -0,49 34.02% | -0,36 -0,02 -1700% | -0,36 -0,40 9.24% | -0,48 -0,39 -22.03% | -0,47 -0,43 -10.16% | -0,54 | -0,59 | -0,65 | -0,71 |
| Announcement Date | 03/03/22 | 05/05/22 | 03/08/22 | 02/11/22 | 02/03/23 | 03/05/23 | 07/08/23 | 01/11/23 | 28/03/24 | - | - | - | - |
| Today 03:30 pm | AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release |
| Today 04:00 pm | SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today 04:00 pm | REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| Today 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 06/05/2024 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | MERUS N.V.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | VAXCYTE, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for INmune Bio, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- INMB Stock
- Calendar INmune Bio, Inc.
